×

Valeant bets on pink pill

3:24 PM ET Thu, 20 Aug 2015

Shares of Valeant are down 6 percent after buying Sprout Pharmaceuticals, the maker of the "female Viagra" drug. CNBC's Meg Tirrell discusses drug deals.